| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |